Know anyone giving birth soon?

Little Devan has less than 12 wks to find a matching bone marrow OR cord-blood donation. They're especially interested in folks of mixed South-Asian/European
ancestry like Devan, but *anyone* could be a match.

4-year old Devan has a rare form of high risk leukemia knowns as APML, or acute promyelocytic leukemia.

The test is a painless cheek swab done by mail, & banked cord blood is also admissable -so please, get tested and spread the word!
Want to register in person?
If you're in these locations, you can register in person

Find out more at: http://www.matchdevan.com/

Randolph , MA: Friday, May 14, 1PM-5PM
San Mateo, CA: Saturday May 15 9AM-1PM
Mountain View, CA: Sunday May 16 8AM-Noon
Livermore, CA: Sunday May 16 10AM-3PM
Washington, DC: Saturday, May 15, 10AM-4PM

You can also search for drives in your area by zip code here:
http://www.marrow.org/JOIN/Join_in_Person/index.html

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap